An open trial of pentoxifylline in schamberg's disease.

Abstract

Fifteen patients with Schamberg's disease were enrolled in the study. Each patient was given 400mg of pentoxifylline once a day for 8 weeks. Skin biopsy was done in 6 patients to document the disease. Pretreatment and post treatment evaluation were made. There was no objective improvement in any of the patients though 4 reported subjective improvement in their pigmentation.

• Authors: L Kumrah, R George, S George
• Journal: Indian journal of dermatology, venereology and leprology (Indian J Dermatol Venereol Leprol) 2000 Mar-Apr Vol. 66 Issue 2 Pg. 73-5 ISSN: 0378-6323 [Print] United States
• PMID: 20877031 (Publication Type: Journal Article)